FePd Nanozyme- and SKN-Encapsulated Functional Lipid Nanoparticles for Cancer Nanotherapy via ROS-Boosting Necroptosis
- 8 April 2024
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 16 (15) , 18411-18421
Abstract
Cell necroptosis has presented great potential, acting as an effective approach against tumor apoptotic resistance, and it could be further enhanced via accompanying reactive oxygen species (ROS) overexpression. However, whether overproduced ROS assists the necroptotic pathway remains unclear. Thus, iron-palladium nanozyme (FePd NZ)- and shikonin (SKN)-encapsulated functional lipid nanoparticles (FPS-LNPs) were designed to investigate the ROS overexpression-enhanced SKN-induced necroptosis. In this system, SKN acts as an effective necroptosis inducer for cancer cells, and FePd NZ, a sensitive Fenton reaction catalyst, produces extra-intracellular ROS to reinforce the necroptotic pathway. Both in vitro and in vivo antitumor evaluation revealed that FPS-LNPs presented the best tumor growth inhibition efficacy compared with FP-LNPs or SKN-LNPs alone. Meanwhile, induced necroptosis by FPS-LNPs can further trigger the release of damage-associated molecular patterns (DAMPs) and antigens from dying tumor cells to activate the innate immune response. Taking biosafety into consideration, this study has provided a potential nanoplatform for cancer nanotherapy via inducing necroptosis to avoid apoptosis resistance and activate CD8+ T cell immune response.Keywords
Funding Information
- China Postdoctoral Science Foundation (2023M733519)
- Beijing University of Chemical Technology (GZC20230196)
- National Natural Science Foundation of China (21788102, 51971116)
- Key Laboratory of Advanced Materials of Ministry of Education, Tsinghua University (AdvMat-2023-8)
This publication has 47 references indexed in Scilit:
- ADAR1 and ZBP1 in innate immunity, cell death, and diseaseTrends in Immunology, 2023
- Two‐Dimensional Ultra‐Thin Nanosheets with Extraordinarily High Drug Loading and Long Blood Circulation for Cancer TherapySmall, 2022
- Ultra‐Sensitive Iron‐Doped Palladium Nanocrystals with Enhanced Hydroxyl Radical Generation for Chemo‐/Chemodynamic NanotherapyAdvanced Functional Materials, 2021
- Necroptosis-elicited host immunity: GOx-loaded MoS2 nanocatalysts for self-amplified chemodynamic immunotherapyNano Research, 2021
- Ki-67: more than a proliferation markerChromosoma, 2018
- What is the Order of a Reaction?Topics in Catalysis, 2017
- Necroptosis: Pathway diversity and characteristicsSeminars in Cell & Developmental Biology, 2015
- Necroptosis: The Release of Damage-Associated Molecular Patterns and Its Physiological RelevanceImmunity, 2013
- Molecular mechanisms of drug resistanceThe Journal of Pathology, 2005
- Defects in the apoptotic machinery of cancer cells: role in drug resistanceSeminars in Cancer Biology, 2003